Literature DB >> 11119517

Modulation of human immune response by Echinococcus granulosus antigen B and its possible role in evading host defenses.

R Riganò1, E Profumo, F Bruschi, G Carulli, A Azzarà, S Ioppolo, B Buttari, E Ortona, P Margutti, A Teggi, A Siracusano.   

Abstract

By directly suppressing the function of certain immune cell subsets and by stimulating other cell populations related to immunopathology, parasite-derived substances play an important role in the chronic establishment of parasitic disease. Our objective was twofold: (i) to investigate further the role of Echinococcus granulosus antigen B (AgB) in the human early inflammatory response by determining its effect on polymorphonuclear cell (PMN) random migration, chemotaxis, and oxidative metabolism and (ii) to determine its action in acquired immunity by evaluating AgB and sheep hydatid fluid (SHF)-driven Th1 (gamma interferon [IFN-gamma] and interleukin 12 [IL-12]) and Th2 (IL-4 and IL-13) cytokine production by peripheral blood mononuclear cells (PBMC) from 40 patients who had cured or stable or progressive cystic echinococcosis. AgB significantly inhibited PMN recruitment but left their random migration and oxidative metabolism unchanged. Patients' PBMC stimulated with AgB produced IL-4 and IL-13 but did not produce IL-12. They also produced significantly lower IFN-gamma concentrations than did PBMC stimulated with SHF (P = 10(-5)). AgB skewed the Th1/Th2 cytokine ratios towards a preferentially immunopathology-associated Th2 polarization, predominantly in patients with progressive disease. AgB-stimulated patients' PBMC also proliferated less than SHF-stimulated PBMC (P = 9 x 10(-3)). In vitro Th2 cytokine production was reflected in vivo by elevated specific immunoglobulin E (IgE) and IgG4 antibodies binding to AgB. These findings confirm that AgB plays a role in the escape from early immunity by inhibiting PMN chemotaxis. They also add new information on the host-parasite relationship, suggesting that AgB exploits the activation of T helper cells by eliciting a nonprotective Th2 cell response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119517      PMCID: PMC97883          DOI: 10.1128/IAI.69.1.288-296.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Echinococcus granulosus human infection stimulates low avidity anticarbohydrate IgG2 and high avidity antipeptide IgG4 antibodies.

Authors:  S Sterla; H Sato; A Nieto
Journal:  Parasite Immunol       Date:  1999-01       Impact factor: 2.280

2.  Immunological responses to antigen B from Echinococcus granulosus cyst fluid in hydatid patients.

Authors:  S Ioppolo; S Notargiacomo; E Profumo; C Franchi; E Ortona; R Rigano; A Siracusano
Journal:  Parasite Immunol       Date:  1996-11       Impact factor: 2.280

3.  Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis.

Authors:  R Riganò; E Profumo; B Buttari; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

4.  A specific diagnostic antigen of Echinococcus granulosus with an apparent molecular weight of 8 kDA.

Authors:  S E Maddison; S B Slemenda; P M Schantz; J A Fried; M Wilson; V C Tsang
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

5.  Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.

Authors:  D T Fearon; L A Collins
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

6.  An image processing workstation for automatic evaluation of human granulocyte motility.

Authors:  A Azzarà; M Chimenti; L Azzarelli; E Fantini; G Carulli; F Ambrogi
Journal:  J Immunol Methods       Date:  1992-04-08       Impact factor: 2.303

Review 7.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

8.  Cloning and expression of a cDNA encoding an elongation factor 1beta/delta protein from Echinococcus granulosus with immunogenic activity.

Authors:  P Margutti; E Ortona; S Vaccari; S Barca; R Riganò; A Teggi; F Muhschlegel; M Frosch; A Siracusano
Journal:  Parasite Immunol       Date:  1999-09       Impact factor: 2.280

9.  Cellular immune responses of hydatid patients to Echinococcus granulosus antigens.

Authors:  A Siracusano; A Teggi; F Quintieri; S Notargiacomo; F De Rosa; G Vicari
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease.

Authors:  R Riganò; E Profumo; S Ioppolo; S Notargiacomo; E Ortona; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

View more
  47 in total

1.  Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates.

Authors:  R Riganò; S Ioppolo; E Ortona; P Margutti; E Profumo; M D Ali; B Di Vico; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

2.  Effects of protoscoleces and AgB from Echinococcus granulosus on human neutrophils: possible implications on the parasite's immune evasion mechanisms.

Authors:  Veridiana Gomes Virginio; Lorena Taroco; Ana Lía Ramos; Ana Maria Ferreira; Arnaldo Zaha; Henrique Bunselmeyer Ferreira; Ana Hernández
Journal:  Parasitol Res       Date:  2006-11-17       Impact factor: 2.289

3.  Immunogenicity of two Echinococcus granulosus antigens EgA31 and EgTrp in mice.

Authors:  M Fraize; M E Sarciron; S Azzouz; N Issaadi; G Bosquet; A F Petavy
Journal:  Parasitol Res       Date:  2005-04-12       Impact factor: 2.289

4.  Screening of an Echinococcus granulosus cDNA library with IgG4 from patients with cystic echinococcosis identifies a new tegumental protein involved in the immune escape.

Authors:  E Ortona; P Margutti; F Delunardo; V Nobili; E Profumo; R Riganò; B Buttari; G Carulli; A Azzarà; A Teggi; F Bruschi; A Siracusano
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

5.  Echinococcus granulosus antigen B impairs human dendritic cell differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response.

Authors:  Rachele Riganò; Brigitta Buttari; Elisabetta Profumo; Elena Ortona; Federica Delunardo; Paola Margutti; Vincenzo Mattei; Antonella Teggi; Maurizio Sorice; Alessandra Siracusano
Journal:  Infect Immun       Date:  2007-01-08       Impact factor: 3.441

6.  The secretome of a parasite alters its host's behaviour but does not recapitulate the behavioural response to infection.

Authors:  Chloé Suzanne Berger; Nadia Aubin-Horth
Journal:  Proc Biol Sci       Date:  2020-04-15       Impact factor: 5.349

7.  Human cystic echinococcosis: old problems and new perspectives.

Authors:  Alessandra Siracusano; Antonella Teggi; Elena Ortona
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-11-01

8.  The Echinococcus granulosus antigen B gene family comprises at least 10 unique genes in five subclasses which are differentially expressed.

Authors:  Wenbao Zhang; Jun Li; Malcolm K Jones; Zhuangzhi Zhang; Li Zhao; David Blair; Donald Peter McManus
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

9.  Immunoblotting with human native antigen shows stage-related sensitivity in the serodiagnosis of hepatic cystic echinococcosis.

Authors:  Mara Mariconti; Chiara Bazzocchi; Francesca Tamarozzi; Valeria Meroni; Francesca Genco; Roberta Maserati; Enrico Brunetti
Journal:  Am J Trop Med Hyg       Date:  2013-12-02       Impact factor: 2.345

Review 10.  Echinococcosis and allergy.

Authors:  Dominique A Vuitton
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.